|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/24 | (2006.01) |
| A61K 9/2054 | (2013.01) | ||
| A61K 9/20 | (2006.01) | ||
| A61K 9/2018 | (2013.01) | ||
| A61K 31/4439 | (2006.01) | ||
| A61K 31/553 | (2013.01) | ||
| A61K 31/553 | (2006.01) | ||
| A61K 31/4439 | (2013.01) | ||
| A61K 31/13 | (2006.01) | ||
| A61P 31/18 | (2018.01) | ||
| A61P 31/18 | (2006.01) | ||
| A61K 9/209 | (2013.01) |
| (11) | Number of the document | 4531816 |
| (13) | Kind of document | T |
| (96) | European patent application number | 24755477.7 |
| Date of filing the European patent application | 2024-08-14 | |
| (97) | Date of publication of the European application | 2025-04-09 |
| (45) | Date of publication and mention of the grant of the patent | 2025-12-31 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2024/042251 |
| Date | 2024-08-14 |
| (87) | Number | WO 2025/038715 |
| Date | 2025-02-20 |
| (30) | Number | Date | Country code |
| 202363519675 P | 2023-08-15 | US | |
| 23201068 | 2023-09-29 | EP |
| (72) |
ARORA, Priyanka , US
CLAMPFFER, Marina A. , US
FOGARTY, Julie A. , US
|
| (73) |
Gilead Sciences, Inc. ,
333 Lakeside Drive, Foster City, CA 94404,
US
|
| (54) | PHARMACEUTICAL FORMULATIONS OF BICTEGRAVIR AND LENACAPAVIR |
| PHARMACEUTICAL FORMULATIONS OF BICTEGRAVIR AND LENACAPAVIR |